Hormone therapy: maximizing the benefits.

Area of Science:

• Reproductive endocrinology
• Menopause management
• Hormone therapy research

Background:

• Recent studies on hormone therapy (HT) have generated controversy regarding its safety and efficacy.
• HT remains a cornerstone for managing menopausal symptoms and preventing osteoporosis.
• Vaginal atrophy is a common and distressing symptom of menopause that HT effectively treats.

Purpose of the Study:

• To evaluate the overall benefits and risks of hormone therapy (HT) in postmenopausal women.
• To discuss the implications of recent HT findings on clinical practice.
• To emphasize the importance of individualized HT regimens.

Main Methods:

• Review of recent scientific literature on hormone therapy.
• Analysis of benefits including symptom relief, osteoporosis prevention, and potential protection against colorectal cancer and cardiovascular disease.
• Assessment of risks, including a potential small increase in breast cancer risk with combined HT.

Main Results:

• HT is highly effective for treating climacteric symptoms and vaginal atrophy.
• HT significantly reduces morbidity and mortality associated with fractures.
• A potential small increase in breast cancer risk with combined HT must be weighed against substantial benefits.

Conclusions:

• The benefits of HT in managing menopausal symptoms and preventing osteoporosis are indisputable.
• Individualizing HT regimens and doses is crucial for maximizing benefits and minimizing risks.
• HT can improve well-being, quality of life, and potentially offer protection against other diseases.